GE licenses Syntermed diagnostic tool for heart failure
BOSTON—GE Healthcare has licensed Syntermed's SyncTool, a new diagnostic tool for heart failure, and demonstrated the tool on its GE Xeleris 2 workstations at the American Society of Nuclear Cardiology (ASNC), Sept. 10-14.
GE said it is licensing SyncTool software as part of an Emory Cardiac Toolbox upgrade on all Xeleris 2 workstations, which could help to predict which heart failure patients will benefit from cardiac resynchronization therapy.
SyncTool uses multiharmonic phase analysis, a technology developed by Emory University medical scientists Ernest Garcia, PhD, and Ji Chen, PhD, and was licensed exclusively to Syntermed by Emory in June. The software provides a new automated analysis of left ventricular function of conventional ECG-gated SPECT myocardial perfusion imaging, according to GE.
GE said it is licensing SyncTool software as part of an Emory Cardiac Toolbox upgrade on all Xeleris 2 workstations, which could help to predict which heart failure patients will benefit from cardiac resynchronization therapy.
SyncTool uses multiharmonic phase analysis, a technology developed by Emory University medical scientists Ernest Garcia, PhD, and Ji Chen, PhD, and was licensed exclusively to Syntermed by Emory in June. The software provides a new automated analysis of left ventricular function of conventional ECG-gated SPECT myocardial perfusion imaging, according to GE.